Biomarker 11-dh-TXB2 in Blood and Urine Samples From Patients With Prostate Cancer and Healthy Volunteers
Completed
Conditions studied: Prostate Cancer
In brief
RATIONALE: Studying samples of blood and urine from patients with cancer in the laboratory may help doctors identify biomarkers related to cancer. PURPOSE: This research study is looking at a biomarker, 11-dh-TXB2, in blood and urine samples from patients with prostate cancer and healthy volunteers.
Key facts
- Study ID
- NCT00984919
- Run by
- Barbara Ann Karmanos Cancer Institute
- People needed
- 10
- Starts
- 2009-11-01
- Expected to finish
- 2011-02-01
- Last updated by the study team
- 2016-02-15
Who can join
Age: 40 and older, up to 120. Sex: male. Healthy volunteers: accepted.
Where it is running
- Barbara Ann Karmanos Cancer Institute — Detroit, Michigan, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.